- Home
- XXII vs AVGR Comparison
XXII vs AVGR Comparison
Compare XXII & AVGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XXII
- AVGR
- Stock Information
- Founded
- XXII 1998
- AVGR 2007
- Country
- XXII United States
- AVGR United States
- Employees
- XXII N/A
- AVGR N/A
- Industry
- XXII Medicinal Chemicals and Botanical Products
- AVGR Medical/Dental Instruments
- Sector
- XXII Health Care
- AVGR Health Care
- Exchange
- XXII Nasdaq
- AVGR Nasdaq
- Market Cap
- XXII 2.8M
- AVGR 2.6M
- IPO Year
- XXII N/A
- AVGR 2015
- Fundamental
- Price
- XXII $5.10
- AVGR $0.60
- Analyst Decision
- XXII
- AVGR Strong Buy
- Analyst Count
- XXII 0
- AVGR 1
- Target Price
- XXII N/A
- AVGR $5.00
- AVG Volume (30 Days)
- XXII 2.5M
- AVGR 6.7M
- Earning Date
- XXII 11-12-2024
- AVGR 11-07-2024
- Dividend Yield
- XXII N/A
- AVGR N/A
- EPS Growth
- XXII N/A
- AVGR N/A
- EPS
- XXII N/A
- AVGR N/A
- Revenue
- XXII $17,304,000.00
- AVGR $7,262,000.00
- Revenue This Year
- XXII $56.94
- AVGR N/A
- Revenue Next Year
- XXII $2.98
- AVGR $93.49
- P/E Ratio
- XXII N/A
- AVGR N/A
- Revenue Growth
- XXII N/A
- AVGR N/A
- 52 Week Low
- XXII $3.90
- AVGR $0.39
- 52 Week High
- XXII $581.85
- AVGR $5.45
- Technical
- Relative Strength Index (RSI)
- XXII 41.23
- AVGR 44.72
- Support Level
- XXII $4.80
- AVGR $0.55
- Resistance Level
- XXII $12.49
- AVGR $0.83
- Average True Range (ATR)
- XXII 2.00
- AVGR 0.13
- MACD
- XXII 0.36
- AVGR -0.02
- Stochastic Oscillator
- XXII 3.90
- AVGR 13.89
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
About AVGR Avinger Inc.
Avinger Inc is a United States-based medical device company. It is engaged in designing, manufacturing, and selling image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). The products offered by the firm include Lightbox imaging console, the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and Pantheris, an image-guided atherectomy device which is designed to allow physicians to precisely remove arterial plaque in PAD patients. It manufactures and sells products in the United States and internationally of which it generates the majority of the revenue from the sales made in the United States.